Ixazomib for Desensitization (IXADES) in Highly Sensitized Kidney Transplant Candidates: A Phase II Clinical Trial.

ABSTRACT:

SUBMITTER: Wilson N 

PROVIDER: S-EPMC10371382 | biostudies-literature | 2023 Jun

REPOSITORIES: biostudies-literature